¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"proportional sensitivity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proportional bias
    ºñ·ÊÄ¡¿ìħ
  • proportional hazards model
    ºñ·ÊÀ§Çè¸ðÇü
  • proportional reduction
    ºñ·Ê°¨¼Ò
  • proportional variability
    ºñ·Êº¯µ¿¼º
  • cross sensitivity
    ±³Â÷¹Î°¨µµ
  • cellular sensitivity
    ¼¼Æ÷¹Î°¨µµ
  • denervation sensitivity
    Å»½Å°æ¹Î°¨µµ
  • diagnostic sensitivity
    Áø´Ü¹Î°¨µµ
  • disc sensitivity test
    ¿ø¹Ý¹Î°¨°Ë»ç
  • insulin sensitivity index
    Àν¶¸°¹Î°¨Áö¼ö
  • international sensitivity index
    ±¹Á¦¹Î°¨µµÁö¼ö
  • optimal sensitivity
    ÃÖÀû¹Î°¨µµ
  • physics depth sensitivity
    ¹°¸®Àû±íÀ̹ਵµ
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý¹Î°¨µµ
  • spectral sensitivity
    ºÐ±¤¹Î°¨µµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sensitivity
    1.°¨¼ö¼º, °¨°¢, 2.¹Î°¨µµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proportional bias
    ºñ·ÊÆíÀç
  • proportional hazards model
    ºñ·ÊÀ§Çè¸ðÇü
  • proportional reduction
    ºñ·Ê°¨·Â
  • proportional variability
    ºñ·Êº¯µ¿¼º
  • cellular sensitivity
    ¼¼Æ÷¹Î°¨µµ
  • sensitivity control
    °¨µµÁ¶Á¤±â, °¨µµÁ¶Àý
  • sensitivity current
    °¨µµÀü·ù
  • denervation sensitivity
    Å»½Å°æ°ú¹Î, Å»½Å°æ¹Î°¨µµ
  • diagnostic sensitivity
    Áø´Ü¹Î°¨µµ
  • disc sensitivity test
    ¿øÆÇ¹Î°¨°Ë»ç
  • leucine sensitivity hypoglycemia
    ·ù½Å¹Î°¨ÀúÇ÷´çÁõ
  • insulin sensitivity index
    Àν¶¸°°¨¼ºÁö¼ö
  • international sensitivity index
    ±¹Á¦¹Î°¨µµÁö¼ö
  • optimal sensitivity
    ÃÖÀû¹Î°¨µµ
  • oxytocin sensitivity test
    ¿Á½ÃÅä½Å¹Î°¨µµ°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proportional bias
    ºñ·ÊÆíÀç(ÝïÖÇø¶î¤)
  • proportional counter
    ºñ·Ê°è¼ö±â(ËÓËç Ë­ËàË»).
  • proportional counter tube
    ºñ·Ê°è¼ö°ü(ËÓËçË­ËàË´).
  • ISI => International Sensitivity Index
    ±¹Á¦¿¹¹ÎµµÁö¼ö
  • International Sensitivity Index
    ±¹Á¦¿¹¹ÎµµÁö¼ö
  • International Sensitivity Index=ISI
    ±¹Á¦¹Î°¨µµÁö¼ö
  • TB sensitivity plate
    °áÇÙ±Õ°¨¼ö¼ºÆòÆÇ
  • in vitro sensitivity testing
    ½ÃÇè°ü³» °¨¼ö¼º ½ÃÇè
  • insulin sensitivity
    Àν¶¸°°¨(¼ö)¼º.
  • insulin sensitivity index
    Àν¶¸°°¨¼ºÁö¼ö.
  • insulin sensitivity test
    Àν¶¸°°¨¼º½ÃÇè.
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý°ú¹ÎÁõ.
  • radiation sensitivity
    ¹æ»ç¼±°¨¼ö¼º
  • radiation sensitivity test, RST
    ¹æ»ç¼±°¨¼ö¼º°Ë»ç
  • receptor sensitivity
    ¼ö¿ëü °¨¼ö¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mean proportional
    ºñ·ÊÁßÇ×(ËÓËç̴̡).
  • proportional bias
    ºñ·ÊÆíÀç(ÝïÖÇø¶î¤)
  • proportional counter
    ºñ·Ê°è¼ö±â(ËÓËç Ë­ËàË»).
  • proportional counter tube
    ºñ·Ê°è¼ö°ü(ËÓËçË­ËàË´).
  • proportional limit
    ºñ·ÊÇѰè(ËÓËç̰˭).
  • proportional mortality indicator
    ºÎºÐºñ»ç¸ÁÁö¼ö.
  • proportional mortality rate
    ºÎºÐºñ»ç¸Á·ü.
  • proportional reduction
    ºñ·Ê°¨·Â(ÝïçÓÊõæ³).
  • proportional variability
    ºñ·Êº¯µ¿¼º(ÝïÖÇܨÔÑàõ)
  • cellular sensitivity
    ¼¼Æ÷°¨¼ö¼º
  • contrast sensitivity
    ´ëºñ°¨µµ
  • contrast sensitivity chart
    ´ëºñ°¨µµÇ¥
  • corneal sensitivity
    °¢¸·Áö°¢
  • diagnostic sensitivity
    Áø´ÜÀû ¹Î°¨µµ
  • disc sensitivity test
    ¿øÆÇ°¨¼ö¼º°Ë»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proportional counter
    ºñ·Ê°èÃø±â(ÝïÖÇͪö´Ðï)
  • proportional region
    ºñ·Ê±¸¿ª(ÝïÖÇÏ¡æ´)
  • oligomycin-sensitivity-conferring factor
    ¿Ã¸®°í¸¶À̽а¨¼ö¼ººÎ¿©ÀÎÀÚ(Êïáôàõݾæ¨ì×í­)
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý °¨¼ö¼º(Êïáôàõ)
  • sensitivity
    "(¹Î)°¨µµ((ÚÂ)ÊïÓø), °¨¼ö¼º(Êïáôàõ)"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proportional
    ºñÁØÀÇ, ºñ·ÊÀÇ
  • physics depth sensitivity
    ¹°¸®Àû±íÀÌ¿¹¹Îµµ
  • radiation sensitivity
    ¹æ»ç¼±°¨¼ö¼º
  • section sensitivity profile(SSP)
    ÀýÆí¹Î°¨Ãø¸é
  • sensitivity
    °¨µµ, °¨¼ö¼º, °¨ÀÀ¼º, ¹Î°¨¼º(µµ)
  • sensitivity of speed
    °¨µµ
  • sensitivity tests
    °¨µµ½ÃÇè, °¨¼ö(¼º)½ÃÇè
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
ISI infarct size index; initial slope index; injury severity index; Institute for Scientific Information...
MCS malignant carcinoid syndrome; managed care system; massage of the carotid sinus; mesocaval shunt; me...
PMI   1) Point of Maximal Impulse(= Intensity)
  2) Proportional Mortality Index;...
PAV percutaneous aortic valvuloplasty; poikiloderma atrophicans vasculare; posterior arch vein; proporti...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PAV Proportional Assist Ventilation
PMR Proportional Mortality Ratio
TEPC Tissue-Equivalent Proportional Counter
PH proportional hazard
PID proportional integral derivative
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mean proportional
    ºñ·Ê ÁßÇ×
  • proportional
    ºñÁØÀÇ, ºñ·ÊÀÇ
  • proportional limit
    ºñ·Ê ÇѰè
    1. º¯Çü¿¡ ºñ·ÊÇÏ¿© Áõ°¡ÇÏ´Â ÃÖ´ë ÀÀ·Â. 2. ÀÀ·Â°ú º¯Çü·ü »çÀÌ¿¡ Á¤ºñ·Ê °ü°è°¡ ¼º¸³ÇÏ´Â ¿µ¿ªÀÇ ÃÖ´ë ÀÀ·Â. 3. °¡ÇØÁø ¿Ü·Â¿¡ ºñ·ÊÇØ º¯ÇüÀÌ ÀϾ´Â ÇѰè ÀÀ·Â ÀÌ»óÀÇ ÀÀ·Â.
  • cellular sensitivity
    ¼¼Æ÷ °¨¼ö¼º
    ¼¼Æ÷°¡ °¨¼ö¼ºÀÌ ÀÖ´Â »óÅ ¶Ç´Â ¼ºÁú·Î¼­, Àڱؿ¡ ´ëÇØ¼­ ºñÁ¤»óÀûÀ¸·Î ¹ÝÀÀÇϰųª ¶Ç´Â ºü¸£°í ¿¹¹ÎÇÏ°Ô ¹ÝÀÀÇÏ´Â »óŸ¦ ³ªÅ¸³»´Â µ¥ Á¾Á¾ »ç¿ëµÈ´Ù.
  • cross sensitivity
    ±³Â÷ °ú¹Î ¹ÝÀÀ
  • dentin sensitivity
    »ó¾ÆÁú °¨¼ö¼º
    Ä¡°ú Áø·á ½Ã »ó¾ÆÁúÀ» ħ¹üÇÒ °æ¿ì ȯÀÚ°¡ µ¿ÅëÀ» ´À³¢´Â Á¤µµ.
  • dietary sensitivity
    À½½Ä¹°¿¡ ´ëÇÑ °ú¹Î¼º
  • disc sensitivity test
    ¿øÆÇ °¨¼ö¼º °Ë»ç
  • local muscle sensitivity
    ±¹¼ÒÀû ±Ù°ú¹Î¼º
  • mechanical sensitivity
    ±â°èÀû °¨µµ
  • optimum sensitivity
    ÃÖÀû °¨µµ
  • oxytocin sensitivity test
    ¿Á½ÃÅä½Å °¨¼ö¼º °Ë»ç
  • pain sensitivity
    µ¿Åë ¹Î°¨µµ
    µ¿Åë ¼ö¿ë±â´Â Ã˰¨À̳ª ¾Ð¹Ú°¨¿¡ ´ëÇØ¼­´Â ¹ÝÀÀÇÏÁö ¾ÊÁö¸¸ Á¶Á÷À» ¼Õ»ó½Ãų Á¤µµÀÇ Ã˰¢¿¡ ´ëÇØ¼­´Â ¹ÝÀÀÇÑ´Ù. µ¿Åë Àü´Þ°è´Â °¡²û µ¿Åë¿¡ °ú¹ÎÇÏ°Ô ¹ÝÀÀÇϴµ¥ À̸¦ µ¿Åë °ú¹ÎÁõÀ̶ó ÇÑ´Ù.
  • radiation sensitivity
    ¹æ»ç¼± °¨¼ö¼º
  • sensitivity
    °¨µµ, °¨¼ö¼º, °¨ÀÀ¼º, ¹Î°¨¼º, ¹Î°¨¼ºµµ, °ú¹Î¼º
    °¨¼ö¼ºÀÌ ÀÖ´Â »óÅ ¶Ç´Â ¼ºÁú·Î¼­, Àڱؿ¡ ´ëÇØ¼­ ºñÁ¤»óÀûÀ¸·Î ¹ÝÀÀÇϰųª ¶Ç´Â ºü¸£°í ¿¹¹ÎÇÏ°Ô ¹ÝÀÀÇÏ´Â »óŸ¦ ³ªÅ¸³»´Â µ¥ Á¾Á¾ »ç¿ëµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
proportional Being in proportion: corresponding in size, degree or intensity, having the same or a constant ratio, of, relating to or used in determining proportions.
(18 Nov 1997)
proportional counter A Geiger-Muller counter operating in the voltage range and under conditions in which pulse height is proportional to the energy of the particles or rays being counted, thus making discrimination between particles or rays of different energies possible.
(05 Mar 2000)
proportional hazards models Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.
(12 Dec 1998)
proportional limit The greatest stress that a material is capable of sustaining without any deviation from proportionality of stress to strain (Hooke's law).
(05 Mar 2000)
acquired sensitivity 1. <immunology> A state of hypersensitivity induced by exposure to a particular antigen (allergen) resulting in harmful immunologic reactions on subsequent exposures, the term is usually used to refer to hypersensitivity to an environmental antigen (atopic allergy or contact dermatitis) or to drug allergy.
The original meaning, now obsolete, included all states of altered immunologic reactivity, immunity as well as hypersensitivity. Gell and Coombs used the term allergic reaction to mean any harmful immunologic reaction causing tissue injury.
2. <study> The medical specialty dealing with diagnosis and treatment of allergic disorders.
(18 Nov 1997)
analytical sensitivity The degree of response to a change in concentration of analyte being measured in an assay; synonymous with the detection limit.
(05 Mar 2000)
antibiotic sensitivity Microbial susceptibility to antibiotics.
See: antibiotic sensitivity test, minimal inhibitory concentration.
(05 Mar 2000)
antibiotic sensitivity test The in vitro testing of bacterial cultures with antibiotics to determine susceptibility of bacteria to antibiotic therapy.
(05 Mar 2000)
pacemaker sensitivity The minimum cardiac activity required to consistently trigger a pulse generator.
(05 Mar 2000)
relative sensitivity The sensitivity of a medical screening test as determined by comparison with the same type of test; e.g., sensitivity of a new serological test relative to sensitivity of an established serological test.
(05 Mar 2000)
chemotherapy drug sensitivity test <investigation> A test to assess a cancerous tissue's response and vulnerability to chemotherapy drugs. This test can help predict a patients response to treatment and suggest which drugs may be useful.
(16 Dec 1997)
microbial sensitivity tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
(12 Dec 1998)
photoallergic sensitivity See: photosensitization.
(05 Mar 2000)
phototoxic sensitivity See: photosensitization.
(05 Mar 2000)
clinical sensitivity Test positivity in disease; ability of a test to correctly identify disease.
See: diagnostic sensitivity.
(05 Mar 2000)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
proportional sensitivity the relationship in which a response bears some quantitative algebraic relationship to the intensity of the stimulus.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sensitivity
    ¹Î°¨µµ
  • sensitivity
    ¹Î°¨(¼º);°¨(¼ö)¼º;°¨±¤µµ
  • proportional
    ±ÕÇüÀâÈù
  • proportional
    ±ÕÇüÀÌ ÀâÈù;ºñ·ÊÀÇ;ºñ·ÊÇ×
  • proportional counter
    ºñ·Ê °è¼ö°ü 9
  • proportional number
    ºñ·Ê¼ö
  • proportional parts
    ºñ·Ê ºÎºÐ
  • proportional region
    ºñ·Ê °è¼ö¿ª
  • proportional representation
    (¼±°ÅÀÇ)ºñ·Ê ´ëÇ¥
  • proportional reserve system
    (Á¤È­ Áغñ¿Í ÁöÆó ¹ßÇà°íÀÇ) ºñ·Ê ÁغñÁ¦
  • proportional tax
    ºñ·Ê¼¼;Á¤·ü¼¼
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á